This is a preview of subscription content, log in via an institution to check access.
Notes
PharmacoEconomics & Outcomes News provides comprehensive coverage of the biomedical literature on health economics and outcomes research, and summarizes information selected from over 1600 journals.
The study was supported by a grant from Pharmacia Corporation, US.
Costs (1999 values) were those related to hospitalisation, physician services, laboratory tests, prescription drugs and procedures.
Costs were those related to diagnostic tests, antiretroviral therapy and counselling. Both costs and outcomes were calculated at a 4% discount rate.
Costs were those related to screening, prophylactic low molecular weight heparin therapy, vascular events prevented and treatment of complications.
Australian dollars.
New antidepressants were those under patent protection in 2000 and included sertraline, paroxetine, nefazodone, venlafaxine, fluvoxamine, mirtazapine and citalopram.
Including nelfinavir, lamivudine and zidovudine.
Only direct costs were considered, including those for drug acquisition, consultations and HIV testing procedures.
Includes reflux symptoms.
National Health Service.
The study was supported in part by an unrestricted grant from Amgen, Inc.
References
Funding for HIV Prevention Programme in Developing Countries
MTCT-Plus program pioneers ongoing HIV/AIDS care for women/children. FDC Reports Blue Sheet Health Pol Biomed Res 2002 5 Jun; 45: 7.
Barrett’s Oesophagus: Rising Costs in the US
Amonkar MM, Kalsekar ID, Boyer JG. The economic burden of Barrett’s esophagus in a Medicaid population. Ann Pharmacother 2002 Apr; 36: 605–11.
Novartis Announces ADHD Education Programme for Patients, Families
Novartis Pharmaceuticals Corporation. Novartis Introduces S.T.A.R.T. — Straight Talk About Responsible Treatment — Now Program to Educate about Appropriate Use of ADHD Medications. Media Release: 4 Jun 2002. Available from: URL: http://www.novartis.com.
Physician Values May Hinder Guideline Adherence
Levine M, Cosby J. Valuing knowledge and the knowledge of values: understanding guideline-incongruent prescribing. J Clin Pharmacol 2002 May; 42: 475–6.
Routine Screening for HIV Infection at STD Clinics Well Worth It
Bos JM, van der Meijden WI, Swart W, et al. Routine HIV screening of sexually transmitted disease clinic attenders has favourable cost-effectiveness ratio in low HIV prevalence settings. AIDS 2002 May 24; 16: 1185–87.
Globalization Brings Change to Healthcare Systems Worldwide
Frenk J, Gómez-Dantés O. Globalization and the challenges to health systems: at critical moments for the world, health has consistently remained one of the few truly universal aspirations. Health Aff 2002 May–Jun; 21: 160–5.
Universal Screening to Prevent Vascular Events not Cost Effective
Clark P, Twaddle S, Walker ID, et al. Cost-effectiveness of screening for the factor V Leiden mutation in pregnancy women. Lancet 2002 Jun 1; 359: 1919–20.
Monitoring US Trends in Purchase of Rx-to-OTC Drugs
Radow J. Rx-To-OTC Consumer purchase trends to be tracked by ACNielsen. Health News Daily [online]. 2002 3 Jun
US Decline in NSAID Use in Accordance with Guidelines?
Ausiello JC, Stafford RS. Trends in medication use for osteoarthritis treatment. J Rheumatol 2002 May; 29: 999–1005.
Drug Education Would Benefit Patients with Cancer Pain
Anderson KO, Richman SP, Hurley J, et al. Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer 2002 Apr 15; 94: 2295–304.
Multidisciplinary High-Intensity Hepatitis C Clinic Worth its Extra Cost
Dolder NM, Wilhardt MS, Morreale AP. Justifying a multidisciplinary high-intensity hepatitis C clinic by using decision analysis. Am J Health Syst Pharm 2002 May 1; 59: 867–71.
HAART Reduces Hospitalization, Increases Use of Outpatient Care
HIV Research Network. Hospital and outpatient health services utilization among HIV-infected patients in care in 1999. J Acquir Immune Deficiency Syndr 2002 May 1; 30: 21–6.
Introduction of GP Specialists in the UK to Benefit Patients
Dhillon R. Joined at the hip: primary and secondary care will fit together more smoothly with the introduction of GPSIs. Pharm Market 2002 May; 13: 26–7.
Electronic Prescribing System to Reduce Drug Costs
Is electronic prescribing on target? Pharmaceut J 2002 May 18; 268: 697.
Diabetes Mellitus Care Programme Launched by Aventis in the US
Avenus launches program to improve diabetes care. Dis Manag News 2002 May 10; 7: 2–3 & 8.
US Big Spender on Healthcare
Reinhardt UE, Hussey PS, Anderson GF. Cross-national comparisons of health systems using OECD data, 1999. Health Aff 2002 May–Jun; 21: 169–81.
New Healthcare Model Saves Lives, Cuts Costs in the US
American Healthways. New patient care model reduces healthcare costs and improves patient care–nationwide adoption could save over $30 billion annually [media release] 2002 May 21. Available from URL: http://www.americanhealthways.com.
Use of Complementary Medicine Common in RA
Buchbinder R, Gingold M, Hall S, et al. Non-prescription complementary treatments used by rheumatoid arthritis patients attending a community-based rheumatology practice. Intern Med J 2002 May–Jun; 32: 208–14.
Pharmacist Interventions Improve Treatment Adherence in HIV Infection
Geletko SM, Poulakos MN. Pharmaceutical services in an HIV clinic. Am J Health Syst Pharm 2002 May 1; 59: 709–13.
Antidepressant Pill Splitting Cuts Costs
Cohen CI, Cohen SI. Potential savings from splitting newer antidepressant medications. CNS Drugs 2002 16(5): 353–8.
Donoghue J. Splitting antidepressant medications: more studies are needed to confirm clinical outcomes and potential savings. CNS Drugs 2002; 16(5): 359–60.
HIV-1 Contacting and Testing Policy Cuts PEP Prescribing, Costs
Greub G, Gallant S, Zurn P, et al. Spare non-occupational HIV post-exposure prophylaxis by active contacting and testing of the source person. AIDS 2002 May 24; 16: 1171–6.
Postma MJ, Bos JM, de Jong-van den Berg LTW, et al. HIV post-exposure prophylaxis: enhancing its pharmaco-economic profile by discriminate prescribing. AIDS 2002 May 24; 16: 1177–9.
Videotape Teaches Inpatients to use Prescribed Medication Correctly
Superior CK, Broyles JE, Oliphant CS, et al. Development and evaluation of a medication education videotape for hospitalized patients. Am J Health Syst Pharm 2002 May 1; 59: 859–61.
Ethnicity, Insurance, Income Affect US Pediatric Drug Costs
Chen AY, Chang R-KR. Factors associated with prescription drug expenditures among children: an analysis of the Medical Expenditure Panel Survey. Pediatrics 2002 May; 109: 728–32.
High Societal Cost of GORD, PUD, Dyspepsia in Sweden
Agréus L, Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. PharmacoEconomics 2002; 20(5): 347–55.
New DM Programmes for US Company
Matria to acquire quality oncology, launch cardiac DM program. Dis Manag News 2002 May 19; 7: 1 & 6.
Guidance on Somatropin Use in GH Deficiency Issued by UK NICE
Institute for Clinical Excellence. Guidance on the use of human growth hormone (somatropin) in children with growth failure. Technology Appraisal Guidance [online] 2002 May; 42. Available from URL: http://www.nice.org.uk.
Europe Lags Behind the US in DM
How transferable are disease management programmes? Pharmaceut J 2002 May 18; 268: 695.
Guidelines Issued for Treating Pediatric CAP in the UK
British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management of Community Acquired Pneumonia in Childhood. Thorax 2002 May; 57 Suppl. 1: 11–4.
Using Ethnicity/Race Data to Eliminate US Healthcare Disparities
Bierman AS, Lurie N, Collins KS, Eisenberg JM. Addressing racial and ethnic barriers to effective health care: the need for better data: health plans can play a critical role in eliminating health disparities by developing viable data collection strategies — and using them. Health Affairs 2002 May–Jun; 21: 91–102.
Traditional/Alternative Medicine Use Backed by WHO
World Health Organization. WHO launches the first global strategy on traditional and alternative medicine [media release]. 2002 May 16. Available from URL: http://www.who.int.
Diabetes DM Lowers Costs, Improves Outcomes
Sidorov J, Shull R, Tomcavage J, et al. Does diabetes disease management save money and improve outcomes? A report of simultaneous short-term savings and quality improvement associated with a health maintenance organization-sponsored disease management program among patients fulfilling health employer data and information set criteria. Diabetes Care 2002 Apr; 25: 684–9.
Dose-Optimization Intervention Produces Cost Savings in the US
Calabrese DC, Baldinger SL. Dose-optimization intervention yields significant drug cost savings. J Manag Care Pharm 2002 Mar–Apr; 8: 146–51.
High Cost of CAP in Hospitalized US Elderly
Kaplan V, Angus DC, Griffin MF, et al. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 2002 Mar 15; 165: 766–72
New Intervention Targets At-Risk Patients with Osteoarthritis, CHF
Prescription Solutions program targets non-compliance. Dis Management News 2002 Apr 25; 7: 7.
Rights and permissions
About this article
Cite this article
Disease Management Update. Dis-Manage-Health-Outcomes 10, 515–525 (2002). https://doi.org/10.2165/00115677-200210080-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00115677-200210080-00008